Study Stopped
The study was terminated early due to recruitment challenges related to the large sample size required to achieve adequate statistical power.
Self Treatment With an Electronic Device for Cognitive Rehabilitation in Patients With Subacute Stroke
1 other identifier
interventional
80
1 country
1
Brief Summary
The objective of this study is to evaluate whether the independent use of an electronic device by a patient with stroke outcomes can enhance the effectiveness of rehabilitative treatment for attentional functions compared to standard treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Oct 2017
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedFirst Submitted
Initial submission to the registry
December 18, 2024
CompletedFirst Posted
Study publicly available on registry
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedAugust 6, 2025
October 1, 2024
4.2 years
December 18, 2024
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Trail Making Test Part A (TMT-A)
The Trail Making Test Part A (TMT-A) is a neuropsychological assessment that measures selective attention and processing speed. Participants connect a series of numbered circles in sequential order as quickly as possible. The score is determined by the time taken to complete the task, with shorter times indicating better performance. Errors may negatively impact the score.
From enrollment (within 2 weeks of stroke onset) to the completion of treatment (2 weeks after the start of treatment)
Secondary Outcomes (4)
Trail Making Test Part B (TMT-B)
From enrollment (within 2 weeks of stroke onset) to the completion of treatment (2 weeks after the start of treatment)
Dual task test
From enrollment (within 2 weeks of stroke onset) to the completion of treatment (2 weeks after the start of treatment)
short version of the Elithorn's Perceptual Maze Test
From enrollment (within 2 weeks of stroke onset) to the completion of treatment (2 weeks after the start of treatment)
Stroop Test
From enrollment (within 2 weeks of stroke onset) to the completion of treatment (2 weeks after the start of treatment)
Study Arms (2)
Rehabilitation with a computerized device
EXPERIMENTALEvery morning both groups received the same face-to-face cognitive treatment using an electronic device. in the afternoon only the experimental group performed self-treatment with the same device for 2 weeks, 5 sessions a week, for a total of 10 sessions.
Rehabilitation with pencil-and-paper exercises
ACTIVE COMPARATOREvery morning both groups received the same face-to-face cognitive treatment using an electronic device. Only the control group performed self-treatment with paper-and-pencil exercises for 2 weeks, 5 sessions a week, for a total of 10 sessions.
Interventions
Each group received face-to-face cognitive rehabilitation with the electronic device for 45 min. The exercises were selected by the therapist and divided into four sessions of 2 to 3 days each. Each session included 40 min of activity and 5 minute of break
In the afternoon, the experimental group performed 60 min. self-guided treatment with the electronic device.
In the afternoon, the control group performed 60 min of cognitive self-treatment with conventional paper-and-pencil instruments. The therapist created a variety of exercises every day
Eligibility Criteria
You may qualify if:
- Diagnosis of ischemic or hemorrhagic stroke
- Within 2 weeks since stroke onset
- Age under 85 years
- Attention deficits as measured by the Trails task or the Broken Hearts subtest in the Oxford Cognitive Screen (OCS)
You may not qualify if:
- Visual impairment documented by clinical history (e.g., cataracts, diabetic retinopathy, glaucoma, hemianopia)
- Uncompensated psychiatric disorders
- Drug or alcohol abuse
- History of dementia
- Severe comprehension disorders as determined by the Semantics subtest in the Oxford Cognitive Screen (OCS)
- Spatial neglect as determined by the Broken Hearts subtest in the OCS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione
Verona, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
December 18, 2024
First Posted
January 1, 2025
Study Start
October 2, 2017
Primary Completion
December 30, 2021
Study Completion
July 31, 2025
Last Updated
August 6, 2025
Record last verified: 2024-10